| Dd3:: A new prostate-specific gene, highly overexpressed in prostate cancer MJG Bussemakers, A Van Bokhoven, GW Verhaegh, FP Smit, ... Cancer research 59 (23), 5975-5979, 1999 | 1580 | 1999 |
| DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer D Hessels, JMTK Gunnewiek, I van Oort, HFM Karthaus, ... European urology 44 (1), 8-16, 2003 | 1026 | 2003 |
| DD3 PCA3 , a Very Sensitive and Specific Marker to Detect Prostate Tumors JB De Kok, GW Verhaegh, RW Roelofs, D Hessels, LA Kiemeney, ... Cancer research 62 (9), 2695-2698, 2002 | 893 | 2002 |
| Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer R Umbas, JA Schalken, TW Aalders, BS Carter, HFM Karthaus, ... Cancer research 52 (18), 5104-5109, 1992 | 826 | 1992 |
| Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer R Umbas, WB Isaacs, PP Bringuier, HE Schaafsma, HFM Karthaus, ... Cancer research 54 (14), 3929-3933, 1994 | 724 | 1994 |
| Sequence variants at the TERT-CLPTM1L locus associate with many cancer types T Rafnar, P Sulem, SN Stacey, F Geller, J Gudmundsson, A Sigurdsson, ... Nature genetics 41 (2), 221-227, 2009 | 713 | 2009 |
| Renal cell carcinoma guideline B Ljungberg, DC Hanbury, MA Kuczyk, AS Merseburger, PFA Mulders, ... European urology 51 (6), 1502-1510, 2007 | 712 | 2007 |
| Allelic loss of chromosomes 16q and 10q in human prostate cancer. BS Carter, CM Ewing, WS Ward, BF Treiger, TW Aalders, JA Schalken, ... Proceedings of the National Academy of Sciences 87 (22), 8751-8755, 1990 | 666 | 1990 |
| Cadherin switching in human prostate cancer progression K Tomita, A van Bokhoven, GJLH van Leenders, ETG Ruijter, CFJ Jansen, ... Cancer research 60 (13), 3650-3654, 2000 | 626 | 2000 |
| Prevention and early detection of prostate cancer J Cuzick, MA Thorat, G Andriole, OW Brawley, PH Brown, Z Culig, ... The lancet oncology 15 (11), e484-e492, 2014 | 625 | 2014 |
| Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy A Haese, A de la Taille, H Van Poppel, M Marberger, A Stenzl, ... European urology 54 (5), 1081-1088, 2008 | 594 | 2008 |
| Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers VB Lokeshwar, T Habuchi, HB Grossman, WM Murphy, SH Hautmann, ... Urology 66 (6), 35-63, 2005 | 581 | 2005 |
| Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors PP Bringuier, R Umbas, HE Schaafsma, HFM Karthaus, FMJ Debruyne, ... Cancer research 53 (14), 3241-3245, 1993 | 530 | 1993 |
| Androgen receptors in endocrine‐therapy‐resistant human prostate cancer TH van der Kwast, J Schalken, JAR de Winter, JCC van Vroonhoven, ... International journal of cancer 48 (2), 189-193, 1991 | 482* | 1991 |
| ETS gene fusions in prostate cancer: from discovery to daily clinical practice SA Tomlins, A Bjartell, AM Chinnaiyan, G Jenster, RK Nam, MA Rubin, ... European urology 56 (2), 275-286, 2009 | 480 | 2009 |
| Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer D Hessels, FP Smit, GW Verhaegh, JA Witjes, EB Cornel, JA Schalken Clinical Cancer Research 13 (17), 5103-5108, 2007 | 475 | 2007 |
| Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer GHJM Leyten, D Hessels, SA Jannink, FP Smit, H de Jong, EB Cornel, ... European urology 65 (3), 534-542, 2014 | 474 | 2014 |
| Detection of high-grade prostate cancer using a urinary molecular biomarker–based risk score L Van Neste, RJ Hendriks, S Dijkstra, G Trooskens, EB Cornel, ... European urology 70 (5), 740-748, 2016 | 434 | 2016 |
| Down-Regulation of the KAI1 Metastasis Suppressor Gene during the Progression of Human Prostatic Cancer Infrequently Involves Gene Mutation or Allelic Loss JT Dong, H Suzuki, SS Pin, GS Bova, JA Schalken, WB Isaacs, JC Barrett, ... Cancer Research 56 (19), 4387-4390, 1996 | 409 | 1996 |
| Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ... Annals of Oncology 26 (8), 1589-1604, 2015 | 388 | 2015 |
